UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016699
Receipt number R000019380
Scientific Title The efficacy of High Flow Nasal Cannula Oxygen to prevent respiratory failure after extubation
Date of disclosure of the study information 2015/03/09
Last modified on 2015/07/12 21:05:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of High Flow Nasal Cannula Oxygen to prevent respiratory failure after extubation

Acronym

The efficacy of HFNC to prevent respiratory failure after extubation

Scientific Title

The efficacy of High Flow Nasal Cannula Oxygen to prevent respiratory failure after extubation

Scientific Title:Acronym

The efficacy of HFNC to prevent respiratory failure after extubation

Region

Japan


Condition

Condition

respiratory failure after extubation

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To consider whether High Flow Nasal Cannula Oxygen is effective for the prevention of the respiratory failure after extubation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

reintubation within 72 hours after extubation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Patients who receive oxygen through the HFNC after extubation

Interventions/Control_2

Patients who receive oxygen through the Ventury mask after extubation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. 20 years of age or older
2. the risk of reintubation as follows: 65 years of olders, chronic heart failure, chronic respiratory disorders, Body mass index 30 or more, a PaO2/FiO2 less than or equal to 300 in spontaneous breathing trial
3.patients mechanically ventilated for more than 48 hours
4.patients successfully passed a spntaneous breathing trial(FiO2 0.4 or less, PEEP 5 or less)

Key exclusion criteria

1. under 20 years of age
2. a pregnant woman
3. tracheostomy
4. planned postextubation NPPV

Target sample size

110


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Eiji Isotani

Organization

Tokyo Women's Medical University Medical Center East

Division name

Department of Emergency and Critical Care Medicine

Zip code


Address

2-1-1 Nisiogu, Arakawa-ku, Tokyo

TEL

03-3810-1111

Email

isotaner@dnh.twmu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroyuki Takahashi

Organization

Tokyo Women's Medical University Medical Center East

Division name

Department of Emergency and Critical Care Medicine

Zip code


Address

2-1-1 Nisiogu, Arakawa-ku, Tokyo

TEL

03-3810-1111

Homepage URL


Email

htakahashi-tmd@umin.ac.jp


Sponsor or person

Institute

Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2015 Year 03 Month 03 Day

Date of IRB


Anticipated trial start date

2015 Year 03 Month 09 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 03 Month 03 Day

Last modified on

2015 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019380


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name